BangladeshFilariasisEliminationProgramme SummaryReportfor CentreofNeglectedTropicalDiseases,Liverpool,UK

IntroductionandRationale In Bangladesh, the disease is present all over the country with highest endemicity in northernpartsofthecountry.Outof147millionpeople,about20millionpeopleinthearea has been suffering from the disease, most of which are children. The exact figures of filariasis in Bangladesh are not known, but it is endemic in 33 districts out of 64 districts as reveled by ICT by LQAS, completed in 2002 and 2004. There is high endemicity of filarisis in Nilphamari, Thakurgaon, Dinajpur, Rangpur, Panchagarh, Kurigram, Gaibandha, Chapai Nawabganj, Rajshahi and Lalmonirhat. It is estimated that about 70 million are at risk of infection, while 10 million have various forms of clinical deformity and another 10 million aremicrofilaremics. The introduction in recent years of yearly safe single dose regimens with DEC alone or in combinationwithAlbendazoleforsuccessive46yearshasbeenanimportantbreakthrough in filariasis elimination as a public health problem. The global strategy for elimination of lymphatic filariasis is now principally based on annual single dose treatment of all the eligible members of at risk endemic communities. The challenges to reach adequate treatment coverage and sustain drug delivery to all high risk communities are difficult to achieve by the health services alone. These services are often have little involvement in the treatmentprogrammes. Objectives GeneralObjective To determine the mass drug administration coverage status and the nature of drug reactions in the study area with a view to inform the findings to the concerned authority to takenecessarysteps. SpecificObjectives 1) TofindouttheMDAcoveragestatusamongsamplesofthestudyarea. 2) To identify the nature of drug reactions with duration due to MDA among the studysamples. 3) Tofindoutthecausesofnottakingtheantifilarialdrugsamongstudysamples. KeyVariables 1. Ageofhouseholdmembers 2. Sexofthehouseholds 3. Ingestionofdrugs 4. Causesofnottakingdrugs 5. Observedcoverage 6. Actualcoverage 7. Typeofdrugreactions 8. Durationofdrugreaction

MassDrugAdministration
Year 2001 2002 2003 2004 2005 2006 No.Districts 1 4 6 9 12 13 Coverage 93% 87.32% 81.9% Nodata 81.9%

MDAinLalmonirhatandNilphamaridistrict,2008 NameofDistrict Upazila/Paurasava Total population Lalmonirhat LalmonirhatSadar 280,495 Aditmari 236296 Kaliganj 260,006 Hatibandha 246,150 Patgram 230,342 Pourashava 58,795 Total 1,312,084 Nilphamari NilphamariSadar& 436,296 Paurasava Sayedpur 285,768 Dimla 290,569 Domar 249,336 Joldhaka 335,427 Kishoreganj 270,327 Total 1,867,723 Targeted population 275,705 219,455 243,456 227,557 211,912 56,562 1,234,647 406,000 260,051 275,945 230,213 301,885 248,422 1,722,516 Reportedcoverage MDA* 275,723 219,455 243,456 226,555 211,870 55,923 1,232,982 406,000 258,970 275,984 229,030 300,795 248,222 1,719,001

Summary A total of 3,179,807 people were covered in the 7th round of MDA in both districts, Lalmonirhat and Nilphamari. The MDA was undertaken in both areas for a period of 10 consecutivedays. LalmonirhatDistrict The survey findings of Lalmonirhat district showed that the observed coverage status of mass drug administration was 87% and the actual coverage was 91.6% among eligible. The reportedcoveragebyCivilSurgeonwas93.96%. NilphamariDistrict The findings in Nilphamari district showed that the observed coverage and actual coverage was85.5%and88.5%respectivelyamongeligiblepopulation.ThereportedcoveragebyCivil Surgeonwas92.04%.